Absence of inducible costimulator (ICOS) on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact.

被引：0

作者：

Hubbard, VM ^{[1
]}

Eng, JM ^{[1
]}

Tjoe, KH ^{[1
]}

Ramirez-Montagut, T ^{[1
]}

Muriglan, SJ ^{[1
]}

Kochman, AA ^{[1
]}

Terwey, TH ^{[1
]}

Schiro, R ^{[1
]}

Alpdogan, O ^{[1
]}

van den Brink, MRM ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

591

引用

页码：171A / 171A

页数：1

共 50 条

[21] Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect [J].

Huang, Ying ;

Jiao, Yiqun ;

Shi, Peijie ;

Nie, Xiaoli ;

Huang, Wei ;

Choi, Michael ;

Macintyre, Andrew N. ;

Nichols, Amanda ;

MacIver, Nancie J. ;

Chao, Nelson J. ;

Rathmell, Jeffrey ;

Chen, Benny J. .

BLOOD, 2017, 130

[22] T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor [J].

Jiang, Hua ;

Fu, Denggang ;

Bidgoli, Alan ;

Paczesny, Sophie .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[23] Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response [J].

Chorny, A ;

Gonzalez-Rey, E ;

Fernandez-Martin, A ;

Ganea, D ;

Delgado, M .

BLOOD, 2006, 107 (09) :3787-3794

[24] IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease [J].

Ramirez-Montagut, Teresa ;

Chow, Andrew ;

Kochman, Adam A. ;

Smith, Odette M. ;

Suh, David ;

Sindhi, Hamad ;

Lu, Sydney ;

Borsotti, Chiara ;

Grubin, Jeremy ;

Patel, Neel ;

Terwey, Theis H. ;

Kim, Theo D. ;

Heller, Glenn ;

Murphy, George F. ;

Liu, Chen ;

Alpdogan, Onder ;

van den Brink, Marcel R. M. .

JOURNAL OF IMMUNOLOGY, 2007, 179 (03) :1669-1680

[25] Vaccine induced graft-versus-tumor effects are separable from graft-versus-host disease. [J].

Teshima, T ;

Mach, N ;

Hill, GR ;

Dranoff, G ;

Ferrara, JLM .

BLOOD, 1999, 94 (10) :635A-635A

[26] Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate [J].

Han, Jingjing ;

Ma, Shoubao ;

Gong, Huanle ;

Liu, Shuangzhu ;

Lei, Lei ;

Hu, Bo ;

Xu, Yang ;

Liu, Haiyan ;

Wu, Depei .

FRONTIERS IN IMMUNOLOGY, 2017, 8

[27] Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation [J].

Storb, Rainer ;

Gyurkocza, Boglarka ;

Storer, Barry E. ;

Sorror, Mohamed L. ;

Blume, Karl ;

Niederwieser, Dietger ;

Chauncey, Thomas R. ;

Pulsipher, Michael A. ;

Petersen, Finn B. ;

Sahebi, Firoozeh ;

Agura, Edward D. ;

Hari, Parameswaran ;

Bruno, Benedetto ;

McSweeney, Peter A. ;

Maris, Michael B. ;

Maziarz, Richard T. ;

Langston, Amelia A. ;

Bethge, Wolfgang ;

Vindelov, Lars ;

Franke, Georg-Nikolaus ;

Laport, Ginna G. ;

Yeager, Andrew M. ;

Huebel, Kai ;

Deeg, H. Joachim ;

Georges, George E. ;

Flowers, Mary E. D. ;

Martin, Paul J. ;

Mielcarek, Marco ;

Woolfrey, Ann E. ;

Maloney, David G. ;

Sandmaier, Brenda M. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) :1530-1538

[28] Treatment of graft-versus-host-disease with mesenchymal stromal cells [J].

Kebriaei, Partow ;

Robinson, Simon .

CYTOTHERAPY, 2011, 13 (03) :262-268

[29] In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease [J].

Hartmann, N. ;

Leithaeuser, F. ;

Albers, C. ;

Duyster, J. ;

Moeller, P. ;

Debatin, K-M ;

Strauss, G. .

LEUKEMIA, 2011, 25 (05) :848-855

[30] In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease [J].

N Hartmann ;

F Leithäuser ;

C Albers ;

J Duyster ;

P Möller ;

K-M Debatin ;

G Strauss .

Leukemia, 2011, 25 :848-855

← 1 2 3 4 5 →